Citius Pharmaceuticals (CTXR) and Citius Oncology (CTOR) announced “promising” preliminary results from an ongoing ...

Welcome to the Merck & Company Q3 sales and earnings conference call. [Operator instructions] This call is being recorded.

TME Pharma N.V. (Euronext Growth Paris: ALTME), a clinical-stage biotechnology company focused on developing novel therapies for trea ...

Positive feedback received from US FDA regarding the planned TACTI-004 Phase III in first-line non-small cell lung cancer successfully concluding ...

3A or 3B non-small cell lung cancer whose disease did not completely respond to neoadjuvant Keytruda plus platinum-based chemotherapy. Global recruitment has also started for this trial, with the ...

She had radiation, chemotherapy and surgery to remove the ... Her last treatment in 2020 was Keytruda, a prescription immunotherapy drug used to treat many types of cancer. Gemberling is currently ...

To be eligible for the trial, patients must have stage II, IIIA, or IIIB NSCLC and have not achieved pathological complete response after neoadjuvant Keytruda plus chemotherapy and surgical resection.

Magic mouthwash is a mouth rinse often prescribed for people with mouth sores (oral mucositis) caused by chemotherapy, radiation therapy, and some targeted therapies. It is also used for oral thrush ...

Patients who received PD-(L)1 inhibitors plus chemotherapy had better progression-free and overall survival than patients who received chemotherapy alone. Results of a meta-analysis suggest that ...

KEYTRUDA plus chemotherapy is the first approval in the EU for an anti-PD-1 therapy combined with chemotherapy only for patients with primary advanced or recurrent endometrial carcinoma regardless of ...